WAWOLVERINE ASSET MANAGEMENT LLC
Institutional investor · Portfolio as of Q1 2020
Top Holdings1,442 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
STATE STREET SPDR S&P 500 ETF TRUST CL USD INC | 826,300 | $213M | 3.1% | — | — | — | Decreased — |
INVESCO QQQ TRUST SERIES 1 CL USD INC | 1.1M | $206M | 3.0% | — | — | — | Increased — |
| 50.5M | $178.2M | 2.6% | — | — | — | Increased 56 | |
| 29.4M | $168.5M | 2.4% | — | — | — | Increased 52 | |
| 52.7M | $165.6M | 2.4% | — | — | — | Increased 52 | |
ISHARES RUSSELL 2000 ETF ETF | 1.3M | $143.8M | 2.1% | — | — | — | Increased — |
| 52.5M | $136.8M | 2.0% | — | — | — | Increased 63 | |
| 89.1M | $136.3M | 2.0% | — | — | — | Decreased 0 | |
| 56M | $130M | 1.9% | — | — | — | Increased 56 | |
| 63.4M | $120.7M | 1.8% | — | — | — | Increased 70 | |
STATE STREET SPDR S&P 500 ETF TRUST CL USD INC | 448,700 | $115.7M | 1.7% | — | — | — | Decreased — |
| 81.3M | $113.3M | 1.6% | — | — | — | Increased 76 | |
| 76.7M | $109.3M | 1.6% | — | — | — | Increased 57 | |
ISHARES RUSSELL 2000 ETF ETF | 935,200 | $107M | 1.6% | — | — | — | Increased — |
| 85.5M | $86.5M | 1.3% | — | — | — | Increased 52 | |
| 41.2M | $84.7M | 1.2% | — | — | — | Increased 76 | |
| 70.8M | $83.9M | 1.2% | — | — | — | Increased 63 | |
PROSHARES TR | 1.7M | $78.7M | 1.1% | — | — | — | Decreased — |
| 776,923 | $73.9M | 1.1% | — | — | — | Increased 75 | |
| 65.1M | $69.7M | 1.0% | — | — | — | Increased 75 |
WOLVERINE ASSET MANAGEMENT LLC manages $6.9B across 1442 positions as of Q1 2020. Top holdings: SPY (3.1%), QQQ (3.0%), TELADOC HEALTH INC (2.6%). Fund DNA: Diversified Scout. HoldingsIntel Rating: 2.5/5.0.
Active quarter - 481 new positions, 348 exits, 337 increased. No standout high-conviction moves this quarter. Portfolio: $6.9B across 1442 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer